Bioval names twelve finalists for its 2026 awards as the cluster turns 20

The story so far, in brief; the legwork, and the full article, stay with the original outlet.

Bioval, the biotech cluster of the Valencia region, has picked twelve finalists for its 2026 awards, three in each of four categories. One per category will win, announced at a 15 October gala that also marks 20 years since the association was founded.

For Biotech Impact, the contenders are Tetraneuron, which develops advanced therapies for neurodegenerative diseases; Avamed Synergy, in digital and precision surgery; and Ibions, in personalised cancer nutrition. Researchers María Jesús Vicent, Leonor Cerdá and Amparo Querol compete for Female Leadership; Alfredo García, Irene Extremera and Claudia Herrero for Young Talent, a prize for people under 35; and Vanessa Garzón, Daniel Pellicer and Anna Juan Roch for Science Communication.

The nine-member jury included José Mesa of Columbus Venture Partners and Quique Calabuig of Kaiho Capital. Narrowing the field took "a great deal of work", said Bioval president Ángela Pérez, biotech projects being hard to judge.